SONAZOID 2017年成為全台SONAZOID立梭影(肝臟病灶顯影劑)獨家代理商，該藥為奇異公司全球獨家藥品，可適用於B、C型肝炎患者罹癌與否的早期診斷及治療，亦可適用早期肝癌患者電燒治療之影像輔助。據台灣衛生福利部估計，國內成人B型肝炎帶原者約250萬人，C型肝炎帶原者約40至70萬人，每年約有1萬人被診斷為肝癌。

超音波對比顯影劑CEUS(contrast-enhanced ultrasonography)檢查在日本行之多年，使用相當普遍,做爲肝癌、肝炎的常規檢查利器。對比劑從手臂的靜脈注射後，再經由超音波的接收與接觸，螢幕上呈現出肝腫瘤之血管影像特徵，有助於肝腫瘤的鑑別診斷。早期的對比劑在肝臟內的滯留時間很短，醫師無足夠時間判讀影像，近年來日本使用的對比劑顯影Sonazoid在肝臟內的滯留時間可長達1小時，可以藉由動脈、靜脈相與Kupffer相更清楚地分辨良性與惡性肝腫瘤，擴大了對比劑顯影超音波在肝腫瘤診斷，治療定位及術後追蹤之應用。而這全球獨家有Kupffer phase的超音波顯影劑Sonazoid,因為副作用極低，診斷及定位效果好，甚至可以做為肝臟原發性與轉移性腫瘤篩檢方式。

下載附檔

北榮配藥影片

SONAZOID 台灣上市活動精華剪輯影片

SONAZOID 相關文獻下載

1. Differential Diagnosis of Hepatic Tumors

2. Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions phase 3 multicenter clinical trial.

3. Characterization and Detection of Focal Liver Lesions

4. Real-time -enhanced sonographically guided biopsy or radiofrequency ablation of focal liver lesions using perflurobutane microbubbles sonazoid value of Kupffer

5. Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation clinical impact and health technology assessment.

6. Efficacy of contrast-enhanced ultrasonography in radiofrequency ablation for hepatocellular carcinoma.

7. Identification of sentinel lymph nodes by contrast-enhanced

8. Clinical Application of Perflubutane Microspheres (SONAZOID)

9. Efficacy of contrast-enhanced ultrasonography in radiofrequency ablation for hepatocellular carcinoma.

10. Low mechanical index contrast mode versus high mechanical

11. Contrast-enhanced ultrasonography with Sonazoid for diagnosis

12. Contrast-Enhanced Harmonic Endoscopic Ultrasonography

13. New endoscopic ultrasonography

14. Diagnosing Pancreatic Tumors Using Contrast-enhanced

15. Comparison With Contrast Enhance Ultrasonography With Sonazoid and FDG

16. Contrast-enhanced ultrasonography using Sonazoid is useful

17. Contrast-enhanced Ultrasonography of the Prostate with Sonazoid

18. Contrast-enhanced ultrasonography with Sonazoid for evaluation